AUTL Latest Headlines

Autolus Therapeutics Balances Growth Ambition With Rising Losses

at www.tipranks.com (Tue, 31-Mar 8:08 PM)

Autolus: Transition-Year Execution and Aucatzyl Expansion Underscore Buy-Rated Long-Term Upside

at www.tipranks.com (Fri, 27-Mar 5:05 PM)

Autolus reiterates $120M–$135M AUCATZYL revenue target for 2026 while expanding pivotal trial pipeline

at seekingalpha.com (Fri, 27-Mar 2:26 PM)

Analysts Offer Insights on Healthcare Companies: Kiora Pharmaceuticals (KPRX), Zentalis Pharmaceuticals (ZNTL) and Autolus Therapeutics (AUTL)

at www.tipranks.com (Fri, 27-Mar 12:30 PM)

Autolus Highlights AUCATZYL Launch and Pipeline Advancements

at www.tipranks.com (Fri, 27-Mar 9:11 AM)

Options Volatility and Implied Earnings Moves Today, March 27, 2026

at www.tipranks.com (Fri, 27-Mar 7:05 AM)

Autolus Therapeutics GAAP EPS of -$0.34 misses by $0.07, revenue of $24.29M beats by $0.37M

at seekingalpha.com (Fri, 27-Mar 7:02 AM)